86 related articles for article (PubMed ID: 1671001)
21. Biodistribution of iodine-125 and indium-111 labeled OV-TL 3 intact antibodies and F(ab')2 fragments in tumor-bearing athymic mice.
Massuger LF; Boerman OC; Corstens FH; Verheijen RH; Claessens RA; Poels LG; van den Broek WJ; Kenemans P
Anticancer Res; 1991; 11(6):2051-7. PubMed ID: 1776839
[TBL] [Abstract][Full Text] [Related]
22. Effect of tumor mass and antigenic nature on the biodistribution of labeled monoclonal antibodies in mice.
Watanabe Y; Endo K; Koizumi M; Kawamura Y; Saga T; Sakahara H; Kuroki M; Matsuoka Y; Konishi J
Cancer Res; 1989 Jun; 49(11):2884-9. PubMed ID: 2470499
[TBL] [Abstract][Full Text] [Related]
23. Transforming growth factor-alpha expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene, and overexpression of the transforming growth factor-alpha complementary DNA leads to transformation.
Ciardiello F; McGeady ML; Kim N; Basolo F; Hynes N; Langton BC; Yokozaki H; Saeki T; Elliott JW; Masui H
Cell Growth Differ; 1990 Sep; 1(9):407-20. PubMed ID: 1981145
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical detection of c-erbB-2 expression by neoplastic human tissue using monospecific and bispecific monoclonal antibodies.
Garcia de Palazzo I; Klein-Szanto A; Weiner LM
Int J Biol Markers; 1993; 8(4):233-9. PubMed ID: 7908024
[TBL] [Abstract][Full Text] [Related]
25. On the selection of a tracer for PET imaging of HER2-expressing tumors: direct comparison of a 124I-labeled affibody molecule and trastuzumab in a murine xenograft model.
Orlova A; Wållberg H; Stone-Elander S; Tolmachev V
J Nucl Med; 2009 Mar; 50(3):417-25. PubMed ID: 19223403
[TBL] [Abstract][Full Text] [Related]
26. Biodistribution of indium-111-labeled OC 125 monoclonal antibody after intraperitoneal injection in nude mice intraperitoneally grafted with ovarian carcinoma.
Thédrez P; Saccavini JC; Nolibé D; Simoen JP; Guerreau D; Gestin JF; Kremer M; Chatal JF
Cancer Res; 1989 Jun; 49(11):3081-6. PubMed ID: 2720666
[TBL] [Abstract][Full Text] [Related]
27. High-specific-activity 111In-labeled anticarcinoembryonic antigen monoclonal antibody: biodistribution and imaging in nude mice bearing human colon cancer xenografts.
Jakowatz JG; Beatty BG; Vlahos WG; Porudominsky D; Philben VJ; Williams LE; Paxton RJ; Shively JE; Beatty JD
Cancer Res; 1985 Nov; 45(11 Pt 2):5700-6. PubMed ID: 4053043
[TBL] [Abstract][Full Text] [Related]
28. Regional and systemic distribution of anti-tumor x anti-CD3 heteroaggregate antibodies and cultured human peripheral blood lymphocytes in a human colon cancer xenograft.
Nelson H; Ramsey PS; Kerr LA; McKean DJ; Donohue JH
J Immunol; 1990 Nov; 145(10):3507-15. PubMed ID: 1700013
[TBL] [Abstract][Full Text] [Related]
29. [Basic studies on the 111In labeled antisense oligonucleotide for tumor imaging].
Fujibayashi Y; Nakagawa K; Waki A; Sakahara H; Konishi J; Yokoyama A
Kaku Igaku; 1996 Feb; 33(2):115-22. PubMed ID: 8721099
[TBL] [Abstract][Full Text] [Related]
30. Ligand-like effects induced by anti-c-erbB-2 antibodies do not correlate with and are not required for growth inhibition of human carcinoma cells.
Shawver LK; Mann E; Elliger SS; Dugger TC; Arteaga CL
Cancer Res; 1994 Mar; 54(5):1367-73. PubMed ID: 7907001
[TBL] [Abstract][Full Text] [Related]
31. Assessment of a new anti-HER2 monoclonal antibody, SV2-61gamma: a best concordance with HER2 FISH.
Kitano Y; Umemura S; Ohbayashi H; Takenaga M; Osamura RY
Appl Immunohistochem Mol Morphol; 2007 Dec; 15(4):389-93. PubMed ID: 18091380
[TBL] [Abstract][Full Text] [Related]
32. In vivo kinetics of radiolabeled monoclonal anti-CEA antibodies in animal models.
Hagan PL; Halpern SE; Chen A; Krishnan L; Frincke J; Bartholomew RM; David GS; Carlo D
J Nucl Med; 1985 Dec; 26(12):1418-23. PubMed ID: 4067644
[TBL] [Abstract][Full Text] [Related]
33. Enhanced binding to antigen of monoclonal antibodies modified with a crosslinker.
Ueno H; Masuko T; Wang J; Hashimoto Y
Biochem Biophys Res Commun; 1993 Mar; 191(2):701-8. PubMed ID: 8096384
[TBL] [Abstract][Full Text] [Related]
34. p185c-erbB-2 signal enhances cisplatin-induced cytotoxicity in human breast carcinoma cells: association between an oncogenic receptor tyrosine kinase and drug-induced DNA repair.
Arteaga CL; Winnier AR; Poirier MC; Lopez-Larraza DM; Shawver LK; Hurd SD; Stewart SJ
Cancer Res; 1994 Jul; 54(14):3758-65. PubMed ID: 7913407
[TBL] [Abstract][Full Text] [Related]
35. Immunoreactivity and biodistribution of indium-111-labeled monoclonal antibody to a human high molecular weight-melanoma associated antigen.
Fawwaz RA; Wang TS; Estabrook A; Rosen JM; Hardy MA; Alderson PO; Srivastava SC; Richards P; Ferrone S
J Nucl Med; 1985 May; 26(5):488-92. PubMed ID: 3989605
[TBL] [Abstract][Full Text] [Related]
36. [Imaging and biodistribution of 111In-labeled anti-carcinoembryonic antigen monoclonal antibodies in nude mice bearing human colon cancer xenografts].
Wu H
Zhonghua Zhong Liu Za Zhi; 1989 Jul; 11(4):254-6. PubMed ID: 2625105
[TBL] [Abstract][Full Text] [Related]
37. Generation of monoclonal antibody CIBCgp185 against C-erbB-2 oncoprotein and its clinical evaluation.
Meenakshi A; Kumar RS; Kumar NS
Hum Antibodies; 2001; 10(3-4):101-7. PubMed ID: 11847421
[TBL] [Abstract][Full Text] [Related]
38. Differences in experimental tumor localization of dual-labeled monoclonal antibody.
Khaw BA; Cooney J; Edgington T; Strauss HW
J Nucl Med; 1986 Aug; 27(8):1293-9. PubMed ID: 3734902
[TBL] [Abstract][Full Text] [Related]
39. Significance of erbB-2 gene product as a target molecule for cancer therapy.
Ishida T; Tsujisaki M; Hanzawa Y; Hirakawa T; Hinoda Y; Imai K; Yachi A
Scand J Immunol; 1994 May; 39(5):459-66. PubMed ID: 7910704
[TBL] [Abstract][Full Text] [Related]
40. The role of erbB-2 and its ligands in growth control of malignant breast epithelium.
Lupu R; Dickson RB; Lippman ME
Princess Takamatsu Symp; 1991; 22():49-60. PubMed ID: 1688228
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
